Brussels, 23/08/2011 (Agence Europe) - The European Commission granted clearance on Friday 19 August to the proposed acquisition of CB Diagnostics Holding AB, the holding company of Phadia Holding AB, Sweden, by Thermo Fisher Scientific Inc. of the United States. The Commission decided that the transaction would not raise competition concerns, because the parties are not close competitors and the merged entity would be constrained by sufficient number of third party competitors active in in...